After almost a month of trial, in our third lawsuit against J&J, the jury found for our client, Deborah Giannecchini, and awarded $70.075 million in damages. Read more
The verdict includes between $4 million and $6 million per plaintiff in damages for physical injuries and pain and suffering, and $1 million each to four spouses for loss of consortium. Read more
Mylan added that EpiPen has been classified as a generic since before it acquired the product in 2007. Read more
Teething can be managed without prescription or over-the-counter remedies. Read more
Johnson & Johnson recently warned that its popular Animas One-Touch Ping Insulin Pump is vulnerable to cyber-attacks by hackers. Read more
The first model of StimuCath was approved via 510(k) in 2002. Read more
Patients undergoing chemotherapy with Taxotere were not warned they could potentially experience permanent hair loss. Read more
It is most unfortunate that the Lipitor litigation is now at a standstill, but the case will be appealed. Read more
Our readers may remember that earlier this year a jury returned another verdict against Johnson & Johnson subsidiary Mentor Worldwide LLC in a Georgia federal court. Read more
Johnson & Johnson is headquartered in New Jersey. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.